FOXO4-DRI is a synthetic peptide designed to disrupt the FOXO4–p53 interaction, making it a precise tool for studying cellular senescence, stress-response signaling, and cell cycle regulation. In laboratory research, it is widely used to explore aging-associated pathways, senescent cell clearance, and intracellular mechanisms related to tissue maintenance and longevity biology.

For in‑vitro laboratory research only. Not a drug, food, cosmetic, or veterinary product. Not for human or animal administration.